Fresenius, one of the largest dialysis treatment providers in the country, has partnered with John Hopkins Hospital to make dialysis treatment accessible to all Baltimoreans. The company has an extensive network of dialysis centers throughout the United States, with eight new locations scheduled to open in the Baltimore area.
One of the dialysis centers will be based at the Hopkins flagship hospital, specially designed to treat children with chronic kidney disease. The other seven dialysis centers will be located in Dundalk, Lutherville-Timonium and Baltimore. Hopkins physicians will oversee all of the new centers.
When the kidneys fail to perform their function, removing toxins and waste from the blood, the only suitable treatment option is dialysis. This process entails artificially removing the waste, with each treatment taking around four hours and is typically repeated three times a week.
“Chronic kidney disease is a considerable, but unrecognized health issue in this country,” said Dr. Paul Scheel, division chief of the nephrology department at Johns Hopkins Hospital, in a statement. “We are pleased to be a part of this initiative, dedicated to providing optimal dialysis services to our patients.”
According to the National Institute of Diabetes and Digestive and Kidney Diseases, around 468,000 people are using dialysis in the United States. Fresenius Medical Care North America, a Massachusetts-based renal care company, treats patients throughout the country. Fresenius Kidney Care alone treats around 200,000 patients each year.